Rhythm Pharmaceuticals Announces Six Abstracts to be Presented at The Obesity Society’s Annual Meeting at ObesityWeek ®
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
News
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced,…
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced,…
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
MADISON, Wis., Oct. 10, 2023 (GLOBE NEWSWIRE) — Stem Pharm, Inc., a drug discovery platform…
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
MADISON, Wis., Oct. 10, 2023 (GLOBE NEWSWIRE) — Stem Pharm, Inc., a drug discovery platform…
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
— Enhances diversity and expertise in key areas including scientific, commercial, and financial — TAMPA,…
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
— Enhances diversity and expertise in key areas including scientific, commercial, and financial — TAMPA,…
Taysha Gene Therapies Announces Two Poster Presentations on TSHA-102 in Rett Syndrome at Upcoming European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
DALLAS, Oct. 10, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage…
Taysha Gene Therapies Announces Two Poster Presentations on TSHA-102 in Rett Syndrome at Upcoming European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
DALLAS, Oct. 10, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage…
ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
At the 36th European College of Neuropsychopharmacology congress (ECNP-2023) MADRID, Spain and BOSTON, Oct. 10,…
ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
At the 36th European College of Neuropsychopharmacology congress (ECNP-2023) MADRID, Spain and BOSTON, Oct. 10,…
Kamada Provides Corporate Update on its Israel Operations
REHOVOT, Israel, and HOBOKEN, N.J., Oct. 10, 2023 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA;…
Kamada Provides Corporate Update on its Israel Operations
REHOVOT, Israel, and HOBOKEN, N.J., Oct. 10, 2023 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA;…
BridgeBio Pharma Announces New England Journal of Medicine Publication of Positive Encaleret Proof-of-Concept Phase 2b Results in Patients with Autosomal Dominant Hypocalcemia Type 1 (ADH1)
– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically…
BridgeBio Pharma Announces New England Journal of Medicine Publication of Positive Encaleret Proof-of-Concept Phase 2b Results in Patients with Autosomal Dominant Hypocalcemia Type 1 (ADH1)
– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically…
Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th
WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”)…
Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th
WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”)…
BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
Submitted abstract on CAB-AXL-ADC, BA3011, in non-small cell lung cancer (NSCLC) to the IASLC 2023…